CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 38 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2022. The put-call ratio across all filers is 2.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $662 | -35.7% | 1,497 | -68.1% | 0.00% | – |
| Q4 2022 | $1,029 | -48.6% | 4,687 | -24.9% | 0.00% | – |
| Q3 2022 | $2,000 | -60.0% | 6,239 | -9.4% | 0.00% | – |
| Q2 2022 | $5,000 | -44.4% | 6,886 | -41.7% | 0.00% | – |
| Q1 2022 | $9,000 | -57.1% | 11,802 | -38.2% | 0.00% | – |
| Q4 2021 | $21,000 | -93.1% | 19,101 | -84.4% | 0.00% | – |
| Q3 2021 | $305,000 | +185.0% | 122,123 | +235.8% | 0.00% | – |
| Q2 2021 | $107,000 | -47.0% | 36,367 | -37.0% | 0.00% | – |
| Q1 2021 | $202,000 | -32.9% | 57,713 | -8.9% | 0.00% | – |
| Q4 2020 | $301,000 | +31.4% | 63,371 | +34.8% | 0.00% | – |
| Q3 2020 | $229,000 | +54.7% | 47,019 | +3.5% | 0.00% | – |
| Q2 2020 | $148,000 | -45.2% | 45,447 | -14.0% | 0.00% | – |
| Q1 2020 | $270,000 | +20.5% | 52,825 | +7.5% | 0.00% | – |
| Q4 2019 | $224,000 | -18.2% | 49,125 | +9.8% | 0.00% | – |
| Q3 2019 | $274,000 | +5.8% | 44,725 | +5.2% | 0.00% | – |
| Q2 2019 | $259,000 | +28.9% | 42,525 | +17.4% | 0.00% | – |
| Q1 2019 | $201,000 | +2.0% | 36,220 | +4.2% | 0.00% | – |
| Q4 2018 | $197,000 | +1.5% | 34,774 | +88.0% | 0.00% | – |
| Q3 2018 | $194,000 | -2.0% | 18,500 | +3.8% | 0.00% | – |
| Q2 2018 | $198,000 | +41.4% | 17,822 | +2.0% | 0.00% | – |
| Q1 2018 | $140,000 | -3.4% | 17,468 | -1.5% | 0.00% | – |
| Q4 2017 | $145,000 | +36.8% | 17,743 | +4.2% | 0.00% | – |
| Q3 2017 | $106,000 | +2.9% | 17,025 | 0.0% | 0.00% | – |
| Q2 2017 | $103,000 | -42.8% | 17,025 | -50.0% | 0.00% | – |
| Q1 2017 | $180,000 | -11.8% | 34,050 | +13.3% | 0.00% | – |
| Q4 2016 | $204,000 | +83.8% | 30,050 | +100.0% | 0.00% | – |
| Q3 2016 | $111,000 | -6.7% | 15,025 | +4.0% | 0.00% | – |
| Q2 2016 | $119,000 | +67.6% | 14,453 | +22.5% | 0.00% | – |
| Q1 2016 | $71,000 | +22.4% | 11,800 | +9.3% | 0.00% | – |
| Q4 2015 | $58,000 | +141.7% | 10,800 | +80.0% | 0.00% | – |
| Q3 2015 | $24,000 | – | 6,000 | +35194.1% | 0.00% | – |
| Q2 2015 | $0 | – | 17 | -81.3% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 91 | -94.3% | 0.00% | – |
| Q4 2014 | $6,000 | +20.0% | 1,591 | +25.7% | 0.00% | – |
| Q3 2014 | $5,000 | +25.0% | 1,266 | 0.0% | 0.00% | – |
| Q2 2014 | $4,000 | 0.0% | 1,266 | 0.0% | 0.00% | – |
| Q1 2014 | $4,000 | -20.0% | 1,266 | -6.2% | 0.00% | – |
| Q4 2013 | $5,000 | – | 1,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |